Regan Jennifer has filed 5 insider transactions across 1 company since May 2024.
Most recent transaction: a option exercise of 7894 shares of Accelerate Diagnostics, Inc ($AXDXQ) on May 29, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Regan Jennifer | Director | M | Common Stock | 7894 | $0.00 | 7,894.0000 | 0 | 9999.99% | 0.00% |
| May 29, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Regan Jennifer | Director | M | Common Stock | 4737 | $0.00 | 12,631.0000 | 0 | 60.01% | 0.00% |
| May 29, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Regan Jennifer | Director | M | Restricted Stock Units | 7894 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 29, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Regan Jennifer | Director | M | Restricted Stock Units | 4737 | $0.00 | 18,947.0000 | 0 | 20.00% | 0.00% |
| May 20, 2024 | Accelerate Diagnostics, Inc | $AXDXQ | Regan Jennifer | Director | A | Restricted Stock Units | 66667 | $0.00 | 66,667.0000 | 0 | 9999.99% | 0.00% |